Ad
related to: ipca laboratories ltd products
Search results
Results From The WOW.Com Content Network
Ipca Laboratories Limited is an Indian multinational pharmaceutical company based in Mumbai. ... The various products of the company include formulations, ...
Working with Ipca Laboratories Ltd., Pareek has received "Clinical and Research Excellence (CARE) award 2016" for the category "Clinical Trial Results of the Year" Sponsored by Informa on 27 April 2016 at State Room, Boston, US.
This listing is limited to those independent companies and subsidiaries notable enough to have their own articles in Wikipedia. Both going concerns and defunct firms are included, as well as firms that were part of the pharmaceutical industry at some time in their existence, provided they were engaged in the production of human (as opposed to veterinary) therapeutics.
For premium support please call: 800-290-4726 more ways to reach us
In 1951 Indravadan A Modi had quit his job as a chemist in a Mumbai firm to start Cadila Laboratories with childhood friend Ramanbhai Patel. The company started in a rented bungalow with a capital of Rs 25,000 and achieved a turnover of around Rs 1.25 lakh in its first year of operation.
During the 1940s and 50s, companies like The Gujarat Pharmaceutical and Chemical Works, Sarabhai Chemicals, Atul Products Ltd, Allied and Cadila Laboratories were established. [ 11 ] 1947: The Drugs Laboratory in Vadodara was established, followed by LM College of Pharmacy.
Torrent Pharmaceuticals was established in 1959 by U. N. Mehta as Trinity Laboratories. It was renamed as Torrent Pharmaceuticals in 1971. [5] In 1997, Torrent Pharma and Sanofi established a 50:50 joint venture called Sanofi Torrent for selling Torrent Pharma's products. [6] Torrent exited the joint venture by selling its stake to Sanofi in ...
A meta-analysis of 53 clinical trials has shown that all triptans are effective for treating migraine at marketed doses and that naratriptan, although less effective than sumatriptan and rizatriptan was more effective than placebo in reducing migraine symptoms at two hours [3] and efficacy was demonstrated in almost two thirds of subjects after four hours of treatment.